This week in Under the Microscope, a special report: KBIA's JESSICA PUPOVAC goes looking for the doctors and the dollars – for information on local doctors who receive payments from pharmaceutical companies in exchange for promoting their products.
Reports that Governor Jay Nixon was considering trying to balance the state budget by tapping state universities for about 107 million dollars, including 63 million from the University of Missouri, haven’t been well received. KBIA’s Scarlett Robertson reports the idea appears to be dying down.
By Scarlett Robertson, Columbia MO.
State representative Chris Kelly, a Democrat, says he thinks the plan is inappropriate.
The U.S. Environmental Protection Agency has finalized the first-ever national standards to reduce toxic air emissions from coal and oil-fired power plants. As St. Louis Public Radio's VERONIQUE LACAPRA reports, the new protections will mean big changes for Missouri.
Whoever wins, the 2012 presidential election is sure to change the country, and the farm.
The eventual Republican nominee will have to address numerous farm-related issues. In this era of shrinking budgets, what will happen to crop insurance, agricultural subsidies and the farm bill? With a renewed national focus on the environment and foreign oil dependence, what role will ethanol play in the future? With high land prices, how will family farmers continue to pass their farms to the next generation? How will changes in immigration policy affect farmers?
An independent panel says the U.S Army Corps of Engineers did what it could to prevent this year’s record flooding along the Missouri River. But as St. Louis Public Radio’s VERONIQUE LACAPRA reports, changes will be needed to manage increasingly frequent extreme weather events.
In this week's Health & Wealth update, a story about both health and wealth: drug companies have paid doctors in Missouri close to $19 million over the past few years, according to data compiled by the investigative nonprofit, ProPublica. KBIA's Jessica Pupovac has been looking into the financial relationships between Missouri doctors and drug companies, and I sat down to talk with her about what she's found out.